Bromodomain and extra-terminal proteins in solid tumors: regulators of immune microenvironment and emerging therapeutic targets. [PDF]
Sharma D +4 more
europepmc +1 more source
Hypoxia-activated paclitaxel prodrugs enable PD-L1 degradation to potentiate cancer chemo-immunotherapy. [PDF]
Zhou S +8 more
europepmc +1 more source
Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression. [PDF]
Kim JM +10 more
europepmc +1 more source
BRD4 promotes endodermal cell fate during mammalian lung development. [PDF]
Wen H +18 more
europepmc +1 more source
Development of Second-Generation Acyl Silane Photoaffinity Probes for Cellular Chemoproteomic Profiling. [PDF]
Page ACS +8 more
europepmc +1 more source
Single-cell transcriptome analysis profiles the enlarged subsets of myeloid-biased HSPCs with preleukemic characters in disuse osteoporosis mice. [PDF]
Zhang C +8 more
europepmc +1 more source
Application of HIV-1 viral protein R-derived-peptides as new E3 ligase-binding components of BRD4 degraders. [PDF]
Tsuji K +7 more
europepmc +1 more source
Reactive oxygen species-activated bioorthogonal chemistry in living systems enabled by boronate-caged dihydrotetrazines. [PDF]
Ming D +9 more
europepmc +1 more source
XQ2, a Novel Derivative of Resveratrol, Reactivates Latent HIV‑1 via the Activation of Positive Transcription Elongation Factor B. [PDF]
Lai F +11 more
europepmc +1 more source
Retraction: JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer. [PDF]
Qiu H +7 more
europepmc +1 more source

